Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon gamma - PubMed (original) (raw)
Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon gamma
P Brouckaert et al. J Exp Med. 1989.
Abstract
Plasma samples obtained from patients receiving a 24-h continuous infusion of human recombinant (hr)TNF or a combination of two overlapping, 24-h continuous infusions of hrIFN-gamma and hrTNF were analyzed for IL-6 in a sensitive bioassay. A transient appearance of circulating IL-6 was observed with peak levels between 3 and 6 h after the start of the hrTNF infusion. These peak levels correlated quite well with the dose of hrTNF administered (r = 0.86; p less than 0.001). The maximal value observed was 27.5 ng/ml IL-6 in a sample of a patient receiving 545 micrograms/m2 hrTNF. The combination of hrIFN-gamma (200 micrograms/m2) and hrTNF in the infusions resulted in higher IL-6 levels than a comparable dose of hrTNF alone. A maximal value of 23.5 ng/ml IL-6 was observed in a patient receiving 205 micrograms/m2 hrTNF. No IL-6 was found in the plasma of patients during the 12-h infusion with hrIFN-gamma alone, except for two borderline samples.
Similar articles
- A phase I trial of recombinant human tumor necrosis factor and interferon-gamma: effects of combination cytokine administration in vivo.
Demetri GD, Spriggs DR, Sherman ML, Arthur KA, Imamura K, Kufe DW. Demetri GD, et al. J Clin Oncol. 1989 Oct;7(10):1545-53. doi: 10.1200/JCO.1989.7.10.1545. J Clin Oncol. 1989. PMID: 2506316 - Characteristics of fever and acute-phase response induced in rabbits by IL-1 and TNF.
Morimoto A, Sakata Y, Watanabe T, Murakami N. Morimoto A, et al. Am J Physiol. 1989 Jan;256(1 Pt 2):R35-41. doi: 10.1152/ajpregu.1989.256.1.R35. Am J Physiol. 1989. PMID: 2492162 - Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans.
Lantz M, Malik S, Slevin ML, Olsson I. Lantz M, et al. Cytokine. 1990 Nov;2(6):402-6. doi: 10.1016/1043-4666(90)90048-x. Cytokine. 1990. PMID: 2129506 - Cytokines modulate interleukin-6 production by human salivary gland cell line.
Katz J, Nagler R, Barak S, Livneh A, Baum B, Atkinson J, Shemer J. Katz J, et al. Cell Immunol. 1994 Dec;159(2):211-9. doi: 10.1006/cimm.1994.1308. Cell Immunol. 1994. PMID: 7994755 - Therapeutic properties of biological response modifiers. A discussion of preclinical and clinical studies.
Talmadge JE. Talmadge JE. Contrib Gynecol Obstet. 1989;17:49-62. Contrib Gynecol Obstet. 1989. PMID: 2495895 Review. No abstract available.
Cited by
- Interleukin-6 in clinical medicine.
Bauer J, Herrmann F. Bauer J, et al. Ann Hematol. 1991 Jun;62(6):203-10. doi: 10.1007/BF01729833. Ann Hematol. 1991. PMID: 1854882 Review. - How cytokine networks fuel inflammation: Toward a cytokine-based disease taxonomy.
Schett G, Elewaut D, McInnes IB, Dayer JM, Neurath MF. Schett G, et al. Nat Med. 2013 Jul;19(7):822-4. doi: 10.1038/nm.3260. Nat Med. 2013. PMID: 23836224 Review. No abstract available. - Interleukin-6 and renal cell cancer: production, regulation, and growth effects.
Koo AS, Armstrong C, Bochner B, Shimabukuro T, Tso CL, deKernion JB, Belldegrum A. Koo AS, et al. Cancer Immunol Immunother. 1992;35(2):97-105. doi: 10.1007/BF01741856. Cancer Immunol Immunother. 1992. PMID: 1596939 Free PMC article. - Interleukin-6 and the acute phase response.
Heinrich PC, Castell JV, Andus T. Heinrich PC, et al. Biochem J. 1990 Feb 1;265(3):621-36. doi: 10.1042/bj2650621. Biochem J. 1990. PMID: 1689567 Free PMC article. Review. No abstract available. - Antitumor activity of recombinant interleukin 6 in mice.
Mulé JJ, McIntosh JK, Jablons DM, Rosenberg SA. Mulé JJ, et al. J Exp Med. 1990 Mar 1;171(3):629-36. doi: 10.1084/jem.171.3.629. J Exp Med. 1990. PMID: 2307930 Free PMC article.
References
- J Immunol Methods. 1984 Mar 16;67(2):379-88 - PubMed
- Int J Cancer. 1986 Nov 15;38(5):763-9 - PubMed
- Proc Natl Acad Sci U S A. 1986 Dec;83(24):9679-83 - PubMed
- J Infect Dis. 1988 Mar;157(3):413-20 - PubMed
- Immunol Today. 1988 May;9(5):137-9 - PubMed